We evaluated human alpha-1 antitrypsin (AAT), the prototype endogenous NE inhibitor, as a suppressor of bacterial pneumonia and pneumonia-related pathogenesis. Here, SERPINA1 is linked to susceptibility to pneumonia measurement.